<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04782310</url>
  </required_header>
  <id_info>
    <org_study_id>MS-386-2020</org_study_id>
    <nct_id>NCT04782310</nct_id>
  </id_info>
  <brief_title>Duloxetine vs Pregabalin for Thoracotomy Pain</brief_title>
  <official_title>Effectiveness of Adding Duloxetine to Pregabalin in Treatment of Acute Postoperative and Prevention of Chronic Pain Following Thoracotomy Surgeries; Randomized Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study investigates the effects of preoperative use of oral combination of duloxetine and&#xD;
      Pregabalin in comparison with preoperative oral Pregabalin only in treatment of acute&#xD;
      postoperative and prevention of chronic pain following thoracotomy surgeries.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      75 Patients, undergoing thoracotomy surgery will be randomly allocated into three equal&#xD;
      groups, each (n=25 ), using computerized generated random tables: Group P: will receive oral&#xD;
      Pregabalin 75mg two hour preoperatively, 12 hours postoperative and will continue for one&#xD;
      week twice per day.&#xD;
&#xD;
      Group D:will receive oral duloxetine 30mg two hour preoperatively …will be continued for one&#xD;
      week once per day after breakfast .&#xD;
&#xD;
      Group C: will receive single dose of Pregabalin 75mg + duloxetine 30mg two hour&#xD;
      preoperatively, 75mg pregabalin 12 hour postoperative and then will continue pregabalin twice&#xD;
      per day +duloxetine once after breakfast for one week.&#xD;
&#xD;
      The total amount of morphine consumption in the first 24 hours postoperatively, total amount&#xD;
      of intraoperative fentanyl will be recorded, change in hemodynamics ((heart rate and mean&#xD;
      arterial blood pressure), respiratory rate and oxygen saturation will be monitored and&#xD;
      recorded at 0,2, 4, 8, 12 ,16 &amp;24 hours and Visual analogue scale at 0, 2,4, 8, 12, 16 &amp;24&#xD;
      hours postoperatively then at 3rd, 5th days, 4th week and12th week will be measured.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 10, 2021</start_date>
  <completion_date type="Anticipated">September 15, 2021</completion_date>
  <primary_completion_date type="Anticipated">August 10, 2021</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual analogue scale</measure>
    <time_frame>24 hours postoperative</time_frame>
    <description>Using a ruler, the score is determined by measuring the distance (mm) on the 10-cm line between the &quot;no pain&quot; anchor and the patient's mark, providing a range of scores from 0-100. A higher score indicates greater pain intensity.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Visual analogue scale</measure>
    <time_frame>12 weeks</time_frame>
    <description>Using a ruler, the score is determined by measuring the distance (mm) on the 10-cm line between the &quot;no pain&quot; anchor and the patient's mark, providing a range of scores from 0-100. A higher score indicates greater pain intensity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total dose of intraoperative fentanyl.</measure>
    <time_frame>2 hours intraoperative</time_frame>
    <description>The total dose of intraoperative fentanyle administration rather than the dose used in induction</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart rate</measure>
    <time_frame>24 hours</time_frame>
    <description>Heart rate will be measured preoperative as baseline value, intraoperative and postoperative</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean arterial pressure</measure>
    <time_frame>24 hours postoperative</time_frame>
    <description>Mean arterial blood pressure will be measured preoperative as baseline value, intraoperative and postoperative.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">75</enrollment>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>Group Pregabalin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will receive oral Pregabalin 75mg two hour preoperatively, 12 hours postoperative and will continue for one week twice per day.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group Duloxetine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will receive oral duloxetine 30mg two hour preoperatively …will be continued for one week once per day after breakfast .</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group Pregabalin&amp; Duloxetine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will receive single dose of Pregabalin 75mg + duloxetine 30mg two hour preoperatively, 75mg pregabalin 12 hour postoperative and then will continue pregabalin twice per day +duloxetine once after breakfast for one week.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Pregabalin</intervention_name>
    <description>Pregabalin 75mg two hour preoperatively, 12 hours postoperative and will continue for one week twice per day.</description>
    <arm_group_label>Group Pregabalin</arm_group_label>
    <arm_group_label>Group Pregabalin&amp; Duloxetine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Duloxetine</intervention_name>
    <description>Duloxetine 30mg two hour preoperatively …will be continued for one week once per day after breakfast .</description>
    <arm_group_label>Group Duloxetine</arm_group_label>
    <arm_group_label>Group Pregabalin&amp; Duloxetine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  ● Physical status ASA II, III.&#xD;
&#xD;
               -  Age ≥ 18 and ≤ 65 Years.&#xD;
&#xD;
               -  Body mass index (BMI): &gt; 20 kg/m2 and &lt; 40 kg/m2.&#xD;
&#xD;
               -  Cancer patients undergoing posterolateral thoracotomy incision for cancer lung,&#xD;
                  mesothelioma or metastatectomy from the lung.&#xD;
&#xD;
               -  Patient is able to provide a written informed consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  ● Patients with Known sensitivity or contraindication to drug used in the study&#xD;
&#xD;
               -  History of psychological disorders and/or chronic pain.&#xD;
&#xD;
               -  Previous administration of antidepressants, anticonvulsants, or opioids before&#xD;
                  surgery.&#xD;
&#xD;
               -  Patient refusal.&#xD;
&#xD;
               -  Severe respiratory or cardiac disorders.&#xD;
&#xD;
               -  Advanced liver or kidney disease.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bassant abdelhamid</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cairo University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Bassant Abdelhamid</last_name>
    <phone>01224254012</phone>
    <email>bassantmohamed197@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mary Sabry</last_name>
    <email>marysabry136@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Bassant abdelhamid</name>
      <address>
        <city>Cairo</city>
        <zip>1772</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bassant abdelhamid</last_name>
      <phone>01224254012</phone>
      <email>bassantmohamed197@yahoo.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <reference>
    <citation>Altiparmak B, Güzel Ç, Gümüş Demirbilek S. Comparison of Preoperative Administration of Pregabalin and Duloxetine on Cognitive Functions and Pain Management After Spinal Surgery: A Randomized, Double-blind, Placebo-controlled Study. Clin J Pain. 2018 Dec;34(12):1114-1120. doi: 10.1097/AJP.0000000000000640.</citation>
    <PMID>30020088</PMID>
  </reference>
  <reference>
    <citation>Gilron I, Chaparro LE, Tu D, Holden RR, Milev R, Towheed T, DuMerton-Shore D, Walker S. Combination of pregabalin with duloxetine for fibromyalgia: a randomized controlled trial. Pain. 2016 Jul;157(7):1532-40. doi: 10.1097/j.pain.0000000000000558.</citation>
    <PMID>26982602</PMID>
  </reference>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>March 1, 2021</study_first_submitted>
  <study_first_submitted_qc>March 1, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 4, 2021</study_first_posted>
  <last_update_submitted>May 31, 2021</last_update_submitted>
  <last_update_submitted_qc>May 31, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Bassant M. Abdelhamid</investigator_full_name>
    <investigator_title>Associate professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pregabalin</mesh_term>
    <mesh_term>Duloxetine Hydrochloride</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

